Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey
F. Çobanoglu (Ankara, Turkey), D. Dogru Ersöz (Ankara, Turkey), E. Çakir (AAAnkara, Turkey), T. Sismanlar Eyüboglu (AAAnkara, Turkey), S. Pekcan (AAAnkara, Turkey), G. Cinel (AAAnkara, Turkey), E. Yalçin (AAAnkara, Turkey), N. Kiper (AAAnkara, Turkey), V. Sen (AAAnkara, Turkey), H. Selimoglu Sen (AAAnkara, Turkey), Ö. Ercan (AAAnkara, Turkey), Ö. Keskin (AAAnkara, Turkey), S. Eltan (AAAnkara, Turkey), L. Muhammed Al Shadfan (AAAnkara, Turkey), H. Yazan (AAAnkara, Turkey), D. Ufuk Altintas (AAAnkara, Turkey), S. Sasihüseyinoglu (AAAnkara, Turkey), N. Sapan (AAAnkara, Turkey), S. Çekiç (AAAnkara, Turkey), H. Çokugras (AAAnkara, Turkey), A. Ayzit Atabek (AAAnkara, Turkey), T. Ramasli Gürsoy (AAAnkara, Turkey), A. Tana Aslan (AAAnkara, Turkey), A. Bingöl (AAAnkara, Turkey), A. Basaran (AAAnkara, Turkey), A. Özdemir (AAAnkara, Turkey), M. Köse (AAAnkara, Turkey), M. Hangül (AAAnkara, Turkey), N. Emiralioglu (AAAnkara, Turkey), G. Tugcu (AAAnkara, Turkey), H. Yüksel (AAAnkara, Turkey), Ö. Yilmaz (AAAnkara, Turkey), F. Orhan (AAAnkara, Turkey), Z. Gayretli Aydin (AAAnkara, Turkey), E. Topal (AAAnkara, Turkey), Z. Tamay (AAAnkara, Turkey), A. Süleyman (AAAnkara, Turkey), D. Can (AAAnkara, Turkey), C. Bal (AAAnkara, Turkey), G. Çaltepe (AAAnkara, Turkey), U. Özçelik (AAAnkara, Turkey)
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Çobanoglu (Ankara, Turkey), D. Dogru Ersöz (Ankara, Turkey), E. Çakir (AAAnkara, Turkey), T. Sismanlar Eyüboglu (AAAnkara, Turkey), S. Pekcan (AAAnkara, Turkey), G. Cinel (AAAnkara, Turkey), E. Yalçin (AAAnkara, Turkey), N. Kiper (AAAnkara, Turkey), V. Sen (AAAnkara, Turkey), H. Selimoglu Sen (AAAnkara, Turkey), Ö. Ercan (AAAnkara, Turkey), Ö. Keskin (AAAnkara, Turkey), S. Eltan (AAAnkara, Turkey), L. Muhammed Al Shadfan (AAAnkara, Turkey), H. Yazan (AAAnkara, Turkey), D. Ufuk Altintas (AAAnkara, Turkey), S. Sasihüseyinoglu (AAAnkara, Turkey), N. Sapan (AAAnkara, Turkey), S. Çekiç (AAAnkara, Turkey), H. Çokugras (AAAnkara, Turkey), A. Ayzit Atabek (AAAnkara, Turkey), T. Ramasli Gürsoy (AAAnkara, Turkey), A. Tana Aslan (AAAnkara, Turkey), A. Bingöl (AAAnkara, Turkey), A. Basaran (AAAnkara, Turkey), A. Özdemir (AAAnkara, Turkey), M. Köse (AAAnkara, Turkey), M. Hangül (AAAnkara, Turkey), N. Emiralioglu (AAAnkara, Turkey), G. Tugcu (AAAnkara, Turkey), H. Yüksel (AAAnkara, Turkey), Ö. Yilmaz (AAAnkara, Turkey), F. Orhan (AAAnkara, Turkey), Z. Gayretli Aydin (AAAnkara, Turkey), E. Topal (AAAnkara, Turkey), Z. Tamay (AAAnkara, Turkey), A. Süleyman (AAAnkara, Turkey), D. Can (AAAnkara, Turkey), C. Bal (AAAnkara, Turkey), G. Çaltepe (AAAnkara, Turkey), U. Özçelik (AAAnkara, Turkey). Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey. 4518
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: